U.S. High Court Won’t Review Expert Exclusion In Abilify Tardive Dyskinesia Case
WASHINGTON, D.C. — The U.S. Supreme Court on May 16 declined to review lower court decisions excluding an expert opinion that the maker of the antidepressant Abilify failed to update the...To view the full article, register now.
Already a subscriber? Click here to view full article